메뉴 건너뛰기




Volumn 701, Issue 1, 2011, Pages 29-36

Solid-phase microextraction-gas chromatography-mass spectrometry method validation for the determination of endogenous substances: Urinary hexanal and heptanal as lung tumor biomarkers

Author keywords

Bioanalytical method validation; Endogenous substances; Heptanal; Hexanal; Lung tumor biomarkers; Urine

Indexed keywords

BIOANALYTICAL METHODS; ENDOGENOUS SUBSTANCES; HEPTANAL; HEXANAL; LUNG TUMOR; URINE;

EID: 79960337690     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2011.05.035     Document Type: Article
Times cited : (64)

References (42)
  • 5
  • 36
    • 79960334858 scopus 로고    scopus 로고
    • US FDA, Food and Drug Administration: Center for Drug Evaluation Research, 2001. Guidance for Industry: Bioanalytical Method Validation. Available from:
    • US FDA, Food and Drug Administration: Center for Drug Evaluation Research, 2001. Guidance for Industry: Bioanalytical Method Validation. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatorInformation/Guidances/ucm070107.pdf.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.